Abstract
The paper gives the results of using ozeltamivir in patients with influenza during the epidemic upsurge of morbidity in Russia in the 2006-2007 season. Comparative analysis of nucteotide sequences of viral strains isolated from the patients taking ozeltamivir revealed no marker mutations determining the resistance to this chemical.
Publication types
-
English Abstract
-
Randomized Controlled Trial
MeSH terms
-
Adolescent
-
Adult
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use*
-
Capsules
-
Cytopathogenic Effect, Viral / drug effects
-
Drug Administration Schedule
-
Drug Resistance, Viral / genetics
-
Female
-
Humans
-
Influenza A Virus, H1N1 Subtype* / drug effects
-
Influenza A Virus, H1N1 Subtype* / genetics
-
Influenza A Virus, H1N1 Subtype* / isolation & purification
-
Influenza A Virus, H3N2 Subtype* / drug effects
-
Influenza A Virus, H3N2 Subtype* / genetics
-
Influenza A Virus, H3N2 Subtype* / isolation & purification
-
Influenza, Human / drug therapy*
-
Influenza, Human / epidemiology
-
Influenza, Human / virology
-
Male
-
Middle Aged
-
Moscow / epidemiology
-
Mutation
-
Oseltamivir / administration & dosage
-
Oseltamivir / therapeutic use*
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Capsules
-
Oseltamivir